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ho1p, an essential Rho-type GTPase in 
 
Saccharomyces
cerevisiae
 
, activates its effectors in the GTP-bound
form. Here, we show that Rho1p in secretory vesicles
 
cannot activate 1,3-
 
 
 
-glucan synthase, a cell wall synthe-
sizing enzyme, during vesicular transport to the plasma
membrane. Analyses with an antibody preferentially reacting
with the GTP-bound form of Rho1p revealed that Rho1p
remains in the inactive form in secretory vesicles. Rom2p,
R
 
the GDP/GTP exchange factor of Rho1p, is preferentially
localized on the plasma membrane even when vesicular
transport is blocked. Overexpression of Rom2p results in
 
delocalization of Rom2p and accumulation of 1,3-
 
 
 
-glucan
in secretory vesicles. Based on these results, we propose
that Rho1p is kept inactive in intracellular secretory or-
ganelles, resulting in repression of the activity of the cell
wall–synthesizing enzyme within cells.
 
Introduction
 
Eukaryotic cells consist of several organelles containing distinct
sets of cellular materials, of which there are many. The com-
positions of macromolecules such as proteins, lipids, and
carbohydrates are different in different organelles. Cellular
materials in organelles are localized either by selective transport
from other organelles or by specific synthesis after transport
of requisite biosynthetic enzymes. This theory adequately
explains the mechanisms for the incorporation of cell wall
 
materials in the budding yeast 
 
Saccharomyces cerevisiae
 
. During
morphogenesis of growing yeast cells, cell wall materials are
exclusively incorporated into the surface of buds (Pruyne
and Bretscher, 2000). Among the structural components of
the yeast cell wall (Cabib et al., 2001), the biosyntheses of
mannoproteins and chitin have been well understood. Manno-
proteins are synthesized intracellularly and transported to
the periplasmic space, whereas chitin is synthesized by chitin
synthetase, which is transported to the plasma membrane
through chitosome. In contrast, the biosynthetic process of
1,3-
 
 
 
-glucan polymer and the mechanism of its incorporation
into the cell wall remain largely unknown, although 1,3-
 
 
 
-glucan is the most abundant filamentous component of
the yeast cell wall.
Many enzymes activated at specific organelles use charac-
teristic mechanisms to repress the activity before transported
to the proper destinations. After synthesis and transport to
the specific organelles, such enzymes are activated by irre-
versible processes like posttranslational modifications and
protein folding. Peptide cleavages or chemical modifications
of residues are required during biosynthesis for activation of
many proteases in the lysosome or the vacuole (Wolff et al.,
1996; Turk et al., 2001). Cleavage of the signal peptides is
required for the translocation and activation of mitochondrial
proteins (Du et al., 2000). Like ATPases (Leng et al., 1999),
folding of many enzymes is accomplished during transport
with the assistance of assembly factors that are required to
bring about their activity in the final destinations.
Small GTPases have been known to activate many cellular
regulatory processes. Rho-type GTPases regulate their effectors
involved in cell morphogenesis, membrane trafficking, cell
contraction, cell adhesion, cell motility, gene expression, and
many other cellular processes (Hall, 1998; Kaibuchi et al.,
1999). The activity of Rho-type GTPase is generally regulated
by switching between a GDP-bound inactive state and a
GTP-bound active state with conformational changes (Wei
et al., 1997; Ihara et al., 1998). The budding yeast contains
the essential Rho-type GTPase, Rho1p (Madaule et al.,
1987), like other eukaryotic cells, and is known to have five
proteins as its effector molecules, involved in many cellular
processes (Guo et al., 2001; Saka et al., 2001). Although
Rho1p has been found colocalized with its effectors on the
cell surface in many reported cases (Yamochi et al., 1994;
Qadota et al., 1996; Ayscough et al., 1999), the mechanism
for the activation of Rho1p during transport to the plasma
membrane has remained unclear.
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Among the effectors of Rho1p, Fks1p/2p, a putative cata-
lytic subunit of 1,3-
 
 
 
-glucan synthase (GS),* is an essential
target of upstream signals toward cell wall remodeling and
cell morphogenesis. Rho1p regulates Fks1p/2p through di-
rect interaction (Drgonová et al., 1996; Qadota et al., 1996).
Evidence is accumulating that GS is precisely regulated in re-
sponse to temporally preceding upstream signals (Pruyne
and Bretscher, 2000); First, various factors are involved in
the regulation of GS activity in yeast cells. Both Rom2p, the
GDP/GTP exchange factor (GEF) of Rho1p (Ozaki et al.,
1996), and Wsc family proteins, putative surface sensors on
the cell wall (Gray et al., 1997; Verna et al., 1997; Philip and
Levin 2001), play crucial roles in GS activation through
Rho1p (Sekiya-Kawasaki et al., 2002). Lrg1p, the GTPase-
activating protein of Rho1p, is involved in GS activity on the
plasma membrane (Watanabe et al., 2001). Second, a post-
translational modification of Rho1p by the geranylgeranyl
group is required for both binding with and activation of
Fks1p (Inoue et al., 1999). Third, 
 
FKS2
 
 expression is in-
duced by signals of cell integrity impairment, calcineurin,
and carbon source depletion (Zhao et al., 1998). Finally,
movement of Fks1p on the plasma membrane is required for
proper cell wall remodeling (Utsugi et al., 2002).
Here, we investigated the transport and activation mecha-
nisms of nascent Rho1p in yeast cells. For this purpose, we
analyzed the biosynthetic process of nascent GS exploiting
the methods to assay GS activity both in vivo and in vitro
and to monitor the localization of the product in yeast cells.
Moreover, in order to determine the state of Rho1p directly,
 
*Abbreviations used in this paper: GEF, GDP/GTP exchange factor;
GTP-
 
 
 
S, guanosine 5
 
 
 
-[
 
 
 
-thio]triphosphate; GS, 1,3-
 
 
 
-glucan synthase.
Figure 1. Localization of Rho1p and Fks1p/2p in cells shifted to 37 C. Cells were cultured in YPD at 25 C, shifted to 37 C and cultured for 
2 h. Cultured cells were fixed with formaldehyde and then stained for immunofluorescence microscopy with the anti-Rho1p antibody (left) or 
the anti-Fks1p/2p antibody (right). Strains used were as follows: wild-type (YPH500), sec12, sec1, and sec1 end4.T
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we have produced an antibody that preferentially reacts with
activated Rho1p. Several lines of evidence indicated that
Rho1p remains in the inactive form even in secretory vesi-
cles in the final transport step to the plasma membrane. The
repression of Rho1p activity in secretory vesicles was attrib-
utable to shortage of Rom2p in vesicles. Our results indi-
cated that Rho1p is kept inactive in secretory organelles and
is activated on its arrival at the plasma membrane, where
Rom2p is localized.
 
Results
 
GS is transported to the plasma membrane through 
the secretory pathway
 
We analyzed the biosynthetic and transport processes of na-
scent GS after synthesis of the subunit proteins Rho1p and
Fks1p/2p. To examine how Rho1p and Fks1p/2p are trans-
ported to the plasma membrane, we observed their localiza-
tion when vesicular transport was blocked by 
 
sec
 
 mutations
(Kaiser et al., 1997). Consistent with previous reports
(Yamochi et al., 1994; Qadota et al., 1996; Ayscough et
al., 1999), immunofluorescent microscopic observations re-
vealed that Rho1p and Fks1p/2p were localized at the site of
growth in wild-type cells incubated at 25
 
 
 
C or shifted to
37
 
 
 
C and incubated for 2 h (Fig. 1 and unpublished data).
Rho1p and Fks1p/2p were also localized at the site of growth
in 
 
sec
 
 mutant cells incubated at 25
 
 
 
C (unpublished data).
The localization of Rho1p and Fks1p/2p in 
 
sec
 
 mutant cells
did not alter by a shift to 37
 
 
 
C and a subsequent incubation
for 10 min (unpublished data). However, after incubation of
 
sec
 
 mutant cells at the restrictive temperature for 2 h, Rho1p
and Fks1p/2p were detected not at the site of growth, but in
intracellular organelles (Fig. 1 and unpublished data). In
 
sec12
 
 and 
 
sec16
 
 cells, both of which are defective in transport
from the ER to the Golgi, Rho1p and Fks1p/2p were mislo-
calized to the cytoplasm and had a punctate appearance. In
 
sec1
 
 and 
 
sec6
 
 cells with defects in transport from secretory
vesicles to the plasma membrane, Rho1p and Fks1p/2p were
ubiquitously present. Introduction of the additional muta-
tion of 
 
end4
 
, which leads to defects in endocytosis (Raths et
al., 1993), did not alter the Rho1p and Fks1p/2p localization
in 
 
sec1
 
 mutant cells (Fig. 1). These results implied that
Figure 2. Secretory vesicle fractions of sec1 mutant and wild-type cells. Wild-type (left) or sec1 (right) cells were incubated at 37 C for 2 h, 
lysed, and subjected to differential centrifugations. The high-spin pellet was applied to a Sephacryl™ S-1000 column, and 4-ml fractions were 
collected. (A) Distributions of plasma membrane ATPase (closed circles) and invertase activity (open circles). (B) Immunoblotting analysis of 
GS-containing fractions. The amounts of Rho1p and Fks1p/2p were estimated with the guinea pig antiserum against Rho1p and the mouse 
mAb against Fks1p/2p, respectively. (C) Distributions of GS activity in the presence of GTP- S.T
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Rho1p and Fks1p/2p localized in 
 
sec
 
 mutant cells before the
temperature shift were degraded, and that the intracellular
proteins observed after the temperature shift were newly syn-
thesized proteins in the exocytic pathway. On the basis of
these results, Rho1p and Fks1p/2p may well be transported
to the plasma membrane through the secretory pathway after
their synthesis on the ER.
We confirmed by cell fractionations that movement of na-
scent GS is attributable to vesicular transport. Secretory vesi-
cles were isolated from 
 
sec1
 
 cells cultured at the restrictive
temperature for 2 h after growth at the permissive tempera-
ture and were used to examine whether Rho1p and Fks1p/
2p are detected in secretory vesicle fractions. As described
previously (Walworth and Novick, 1987; McCaffrey et al.,
1991), 
 
sec1
 
 cell lysate was subjected to differential centrifuga-
tions, and the high-speed pellet obtained was fractionated
further on the basis of vesicular size by gel exclusion chroma-
tography. First, we examined the distribution of marker en-
zymes in the final fractions. Invertase, a marker enzyme of
secretory vesicles, was eluted from the column as a single
peak with its maximum at fraction 23 (Fig. 2 A, right).
Plasma membrane ATPase accumulated in secretory vesicles
by 
 
sec1
 
 mutation was co-eluted with invertase. Next, we ex-
amined the distribution of Rho1p and Fks1p/2p by immu-
noblotting analysis and found that the distribution of Fks1p/
2p was indistinguishable from in the elution profile of inver-
tase (Fig. 2 B, right). In 
 
sec1
 
 cells, Rho1p was also found in
the secretory vesicle fractions (Fig. 2 B, right), consistent
with a preceding report (McCaffrey et al., 1991). By con-
trast, Rho1p and Fks1p/2p were not distributed to the secre-
tory vesicle fractions in wild-type cells, but were detected in
fractions centering at 15 (Fig. 2 B, left), which coincided
with the those of plasma membrane based on plasma mem-
brane ATPase activity measurements (Fig. 2 A, left). Thus,
Rho1p and Fks1p/2p are indeed localized in secretory vesi-
cles when vesicular transport is blocked by the 
 
sec1
 
 mutation.
 
Nascent GS is kept inactive in secretory vesicles
 
To identify where in vesicular transport steps nascent GS be-
comes activated, we examined whether 1,3-
 
 
 
-glucan is de-
tected in intracellular organelles. An immunoelectron mi-
croscopic observation with an anti-1,3-
 
 
 
-glucan antibody
revealed that 1,3-
 
 
 
-glucan is not detected in any organelles
other than cell wall layers in wild-type cells (unpublished
data). In addition, after shift to the restrictive temperature,
1,3-
 
 
 
-glucan was not detected in secretory vesicles accumu-
lated in 
 
sec1
 
 cells, but it was observed in cell wall layers (Fig.
3, A and B; Table I). These results suggested that 1,3-
 
 
 
-glu-
can is not synthesized even in secretory vesicles, the final
step of vesicular transport.
To confirm this, we next measured in vivo 1,3-
 
 
 
-glucan
synthesis when vesicular transport was blocked. We labeled
cells with [
 
14
 
C]glucose for 2 h at 25 or 34
 
 
 
C and isolated
fractions containing 1,3-
 
 
 
-glucan from them to estimate the
rate of incorporation into 1,3-
 
 
 
-glucan. We found that in-
corporation is reduced in 
 
sec1
 
 and 
 
sec12
 
 mutant cells after
shift to 34
 
 
 
C (Fig. 3 C). In wild-type cells, significant levels
of incorporation were detected both at 25 and 34
 
 
 
C and
comparable incorporation rates were observed in the 
 
sec
 
 mu-
tants at the permissive temperature. These results further
support the idea that GS remains inactive in intracellular or-
ganelles until it is transported to the plasma membrane.
 
Rho1p is not activated in secretory vesicles
 
When we measure in vitro GS activity of the membrane
fraction, we assay in the presence of an excess amount of
guanosine 5
 
 
 
-[
 
 
 
-thio]triphosphate (GTP-
 
 
 
S), a nonhydro-
lyzable analogue of GTP (Abe et al., 2001), and thus assume
that virtually all of Rho1p is in its active form. The mem-
brane fraction isolated from 
 
rom2
 
 
 
 cells exhibited normal in
vitro GS activity (unpublished data), suggesting that Rho1p
binds GTP-
 
 
 
S without GEF under this condition. There-
fore, if the absence of 1,3-
 
 
 
-glucan synthesis activity in in-
tracellular organelles is caused by a lack of the GTP-bound
form of Rho1p, GS activity of the membrane fraction must
be detectable in the presence of GTP-
 
 
 
S. In contrast, if the
deficiency in enzymatic activity to produce 1,3-
 
 
 
-glucan re-
sults from some other mechanism(s), such as the absence of
an essential GS modification and scarcity of other activators,
GS activity will remain undetectable in the membrane frac-
tion even in the presence of GTP-
 
 
 
S. To distinguish these
two possibilities, we measured the GS activity in the mem-
brane fraction isolated from 
 
sec
 
 mutant cells that were incu-
bated at 25
 
 
 
C or shifted to 37
 
 
 
C and kept at this tempera-
ture for 2 h. The in vitro GS activity in the membrane
fraction of wild-type cells stayed essentially the same after
the temperature shift-up (Fig. 3 D). 
 
sec
 
 mutants cells incu-
bated at the permissive temperature also exhibited signifi-
cant GS activity. GS activity remained significant in the
membrane fraction isolated from 
 
sec1
 
 cells (Fig. 3 D) and
 
sec6
 
 cells (unpublished data) even after the 2-h incubation at
37
 
 
 
C. Fractionation analysis revealed that GS activity was
largely localized to accumulated secretory vesicles in the 
 
sec1
 
mutant (Fig. 2 C and unpublished data). These results
showed that the inability to synthesize 1,3-
 
 
 
-glucan in secre-
tory vesicles is due to the scarcity of the GTP-bound form of
Rho1p. In contrast, the membrane fraction of 
 
sec12
 
 cells
shifted to 37
 
 
 
C and cultured for 2 h exhibited reduced GS
activity. As transport from the ER to the Golgi is defective in
 
sec12
 
, these results suggest that GS in the ER is kept inactive
by mechanism(s) other than deficiency in the GTP-bound
form of Rho1p.
To directly examine the dearth of the GTP-bound form
of Rho1p in secretory vesicles, we produced an antibody that
preferentially reacts with the GTP-bound form of Rho1p
(Fig. 4 A). As an antigen, we used the recombinant Rho1
(G19V) protein (constitutively active mutant protein) puri-
fied from 
 
Trichoplusia ni
 
 insect cells (Inoue et al., 1999).
With the successive use of two columns, we purified an anti-
body that reacts with activated Rho1p with no reactivity
with wild-type Rho1p. To determine the specificity of the
antibody, we immunoprecipitated Rho1p in each state
with the purified antibody. The resultant antibody, anti-
actRho1p, successfully immunoprecipitated Rho1p in the
presence of GTP-
 
 
 
S, while failing to significantly immuno-
precipitate Rho1p in the absence of GTP-
 
 
 
S, even when
GDP is added (Fig. 4 B, right). A control antibody reacting
with wild-type Rho1p immunoprecipitated Rho1p irrespec-T
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tive of the presence of the nucleotides (Fig. 4 B, left). These
results demonstrated that the anti-actRho1p antibody reacts
specifically with the activated form of Rho1p.
Equipped with the anti-actRho1p, we next examined the
localization of activated Rho1p in wild-type and 
 
sec1
 
 cells.
We incubated wild-type and 
 
sec1
 
 cells at 37
 
 
 
C for 2 h, per-
formed fractionation, and immunoprecipitated activated
Rho1p in resultant fractions with the anti-actRho1p anti-
body. Plasma membrane ATPase activity was distributed in
the vicinity of fraction 18 obtained from wild-type cells (Fig.
4 C, top). In contrast, invertase activity was distributed at
around fraction 32 in the case of the 
 
sec1
 
 cells shifted to
37
 
 
 
C. Activated Rho1p was immunoprecipitated in frac-
tions containing the plasma membrane separated from wild-
type cells (Fig. 4 C, bottom). On the other hand, activated
Rho1p was not detected in secretory vesicle fractions isolated
from the 
 
sec1
 
 cells. In the fractionation experiments, the
secretory vesicle fractions contained a larger amount of
Rho1p than the plasma membrane fraction. When we lysed
 
sec1
 
 cells in the presence of an excess amount of GTP and
fractionated by gel chromatography in the absence of GTP,
activated Rho1p was detected in the secretory vesicle frac-
tions, suggesting the stability of Rho1p throughout the ex-
periments. These analyses with the antibody indicated that
Rho1p is in the inactive form in secretory vesicles.
Figure 3. 1,3- -Glucan is not synthesized in intracellular organelles. (A) Immunogold labeling with the anti-1,3- -glucan antibody in sec1 
cells shifted to 37 C and cultured for 2 h. Bar, 1  m. (B) The magnification image. Bar, 200 nm. (C) Reduced incorporation of glucose into 
1,3- -glucan in sec cells. Cells were cultured in YPD in the presence of [
14C]glucose either at 25 C (black bars) or at 34 C for 2 h (white bars). 
The data represent the means and SDs of at least three experiments. (D) GS activity of the membrane fractions isolated from sec mutant cells. 
Cells were cultured either at 25 C (black bars) or at 37 C for 2 h (white bars), from which membrane fractions were isolated and assayed for 
GS activity in the presence of UDP-[
14C]glucose and GTP- S. The data represent the means and SDs of at least four experiments.
Table I. Localization of immunogold labeling with the
anti-1,3- -glucan antibody
Strain [plasmid] Number of gold 
particles in 
intracellular structure 
per cell
Number of gold 
particles in cell wall 
per cell
sec1 20   20 688   404
sec1 [RHO1 (G19V)] 233   75 687   321
sec1 [ROM2] 221   77 542   249
Wild-type
[RHO1 (G19V)]
52   27 768   183
Wild-type [ROM2] 45   16 792   250
Data represent the means and SDs of at least 20 cells.T
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To verify this, we examined the localization of activated
Rho1p with the antibody by immunofluorescence micros-
copy. We incubated wild-type and sec1 cells for 2 h at 25
and 37 C, respectively, and subsequently observed the local-
ization of activated Rho1p. In wild-type cells, Rho1p was
detected either in a large region in a small or large bud or at
the site of bud emergence in an unbudded cell, and in either
case, mostly colocalized with Fks1p/2p (Fig. 5 A). In con-
trast, the anti-actRho1p antibody stained a restricted region
in the small bud in wild-type cells (Fig. 5 B). These results
indicated that Rho1p is activated exclusively at the tip of
small buds, and that wild-type Rho1p in other regions is in
the inactive form. In sec1 cells, activated Rho1p was appar-
ently absent in the intracellular region and the plasma mem-
Figure 4. Localization of activated Rho1p detected with the purified anti-actRho1p antibody. (A) Affinity purification of the anti-actRho1p 
antibody. Antibody was raised against purified recombinant Rho1 (G19V) protein. Antiserum was loaded on an affinity column to which Rho1 
(G19V) protein had been bound. The bound antibody was eluted, applied to another column charged with wild-type Rho1 protein, and the 
flow-through fractions were collected. (B) Immunoprecipitation of Rho1p with the anti-Rho1p (left), or the anti-actRho1p (right) antibody in the 
presence ( ) or absence ( ) of GDP and GTP- S. Rho1p was detected by immunoblotting analysis with the guinea pig antiserum against 
Rho1p. (C) Immunoprecipitation of activated Rho1p. Wild-type (left) or sec1 mutant (right) cells were incubated at 37 C for 2 h. The cells were 
lysed in the presence or absence of 4  M GTP, and fractionated by differential centrifugations. The high-spin pellet was applied to a Sephacryl™ 
S-1000 column without GTP, and 3-ml fractions were collected. Top panels, distribution of plasma membrane ATPase (closed circles) and 
invertase (open circles). Bottom panels, the distributions of activated Rho1p (closed circles and triangles) and total Rho1p (open circles). Aliquots 
of each fraction were assayed by immunoprecipitation with the anti-actRho1p, and detected by immunoblotting analysis with the guinea pig 
antiserum against Rho1p. The relative amount was quantified with a cooled CCD camera (LAS-1000plus; Fuji Photo Film).T
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brane (Fig. 5 B). Together, the results suggested that Rho1p
remains inactive in secretory vesicles and is activated in a re-
stricted region of the plasma membrane.
If accumulation of the inactive form of Rho1p results in
impairment of 1,3- -glucan synthesis in secretory vesicles,
expression of active RHO1 must lead to synthesis of 1,3-
 -glucan in secretory vesicles. Immunoelectron microscopic
observations with the anti-1,3- -glucan antibody revealed
that 1,3- -glucan accumulated in intracellular compart-
ments after expression of the activated form of Rho1p (Fig.
6 A and Table I). In wild-type cells, expression of the acti-
vated form of Rho1p did not result in accumulation of 1,3-
 -glucan in intracellular compartments (Fig. 6 B and Ta-
ble I). To confirm these, we detected 1,3- -glucan by dot
blot analysis. Expression of active RHO1 increased 1,3-
 -glucan in the high-speed pellet of sec1 cells (Fig. 6 C).
Further fractionation analysis with gel chromatography re-
vealed that 1,3- -glucan detected in sec1 cells expressing
active RHO1 was largely localized in secretory vesicles (un-
published data). We also measured in vivo 1,3- -glucan
synthesis in sec1 cells expressing the activated form of
Rho1p (Fig. 6 D). The incorporation of [
14C]glucose was
reduced in sec1 cells at the restrictive temperature. Expres-
sion of active RHO1 in sec1 cells partially restored the in-
corporation. These results demonstrated that expression of
active  RHO1 in sec1 mutant cells leads to 1,3- -glucan
synthesis in secretory vesicles.
Rom2p, GEF of Rho1p, is localized to the plasma 
membrane when vesicular transport is blocked
One possible mechanism for inactivation of Rho1p in secre-
tory vesicles is through the unavailability of Rho1p up-
stream regulatory factors in secretory vesicles. To identify
upstream factors of 1,3- -glucan synthesis, we isolated mul-
ticopy suppressors of a temperature-sensitive GS mutation
(Sekiya-Kawasaki et al., 2002). Among the multicopy sup-
pressor genes obtained, WSC1 and ROM2 were found to be
essential for activating GS upstream of Rho1p. Rom2p is
the GEF of Rho1p (Ozaki et al., 1996), whereas Wsc1p was
proposed to be a transmembrane protein localized on the
plasma membrane and is an upstream regulator of Rom2p
(Philip and Levin, 2001).
Figure 5. Distribution of wild-type Rho1p and activated Rho1p. (A) Colocalization of wild-type Rho1p and Fks1p/2p. Wild-type cells were 
cultured at 25 C, fixed, and stained for immunofluorescence microscopy with the anti-Fks1p/2p antibody (green) or the anti-Rho1p antibody 
(red). (B) Localization of activated Rho1p to a restricted region on the plasma membrane in wild-type cells. Wild-type cells were cultured at 
25 C (top panels), whereas sec1 mutant cells were incubated at 37 C for 2 h (bottom panels), and stained for immunofluorescence microscopy 
with the anti-Fks1p/2p antibody (green) or the anti-actRho1p antibody (red).T
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To test the possibility that Wsc1p or Rom2p is involved in
the inactivation of Rho1p in secretory vesicles, we checked
the localization of Wsc1p and Rom2p in sec1 cells at the re-
strictive temperature. We constructed Wsc1p and Rom2p
with an HA or a GFP tag at the COOH terminus. All the fu-
sion proteins were judged to be functional because the tem-
perature-sensitive growth defect as well as the cell lysis
phenotype in wsc1  and rom2  cells was suppressed by ex-
pression of Wsc1p and Rom2p fusion proteins, respec-
tively (unpublished data). Next, we examined the subcellular
localization of Wsc1-GFP and Rom2-GFP by direct micro-
scopic observations. As described previously (Verna et al.,
1997), Wsc1-GFP was localized at the site of growth in wild-
type and sec1 cells at 25 C, whereas Wsc1-GFP was distrib-
uted all around cells of the sec1 mutant at the restrictive tem-
perature, (unpublished data). These results suggested that
Wsc1-GFP accumulates in secretory vesicles when vesicular
transport is blocked. As formerly reported (Manning et al.,
1997; Audhya and Emr, 2002), Rom2-GFP was localized at
the site of growth in wild-type and sec1 cells at 25 C (unpub-
lished data). Interestingly, culturing at 37 C for 2 h did not
alter the localization of Rom2-GFP both in wild-type (Fig. 7
A) and sec1 cells (Fig. 7 B). In sec1 cells, even after a 4-h in-
cubation at the restrictive temperature, Rom2-GFP re-
mained localized at bud tips (unpublished data). To examine
whether the Rom2-GFP localized to the site of growth at the
restrictive temperature in sec1 cells is a product of synthesis
that took place after blockage of vesicular transport, we ob-
served the Rom2-GFP localization in sec1 cells in the pres-
ence of cycloheximide, a protein synthesis inhibitor. In these
cells, Rom2-GFP was no longer localized at the site of
growth (Fig. 7 C), suggesting that Rom2-GFP localized be-
fore vesicular transport is blocked got degraded. Therefore,
we judge that Rom2-GFP shown in Fig. 7 B was synthesized
after the block on vesicular transport.
To examine whether Rom2p is localized on the plasma
membrane or secretory vesicles close to the plasma mem-
brane, we isolated the plasma membrane from wild-type
cells expressing ROM2-HA, and analyzed the distribution of
the fusion protein. Immunoblotting analysis revealed that
Figure 6. Artificial synthesis of 1,3- -glucan by expression of activated RHO1 
in secretory vesicles. (A) sec1 cells expressing the active form of RHO1. sec1 cells 
transformed with YCpU-RHO1 (G19V) were incubated at 37 C for 2 h, fixed by 
the freeze-substituted fixation method, and 1,3- -glucan was detected by the mouse 
mAb to 1,3- -glucan. Bar, 200 nm. (B) Wild-type cells expressing the active form 
of RHO1. Bar, 200 nm. (C) 1,3- -Glucan in high-speed pellets. Cells were incubated at 37 C for 2 h. The high-spin pellet was resuspended and 
10  g protein was blotted. 1,3- -Glucan was detected by the mouse mAb against 1,3- -glucan. (D) Incorporation of [
14C]glucose into 1,3-
 -glucan in sec1 cells. Cells were cultured in the presence of [
14C]glucose at 25 C (black bars) or at 34 C for 2 h (white bars).T
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Rom2-HA is enriched in plasma membrane fractions (Fig. 8
A). Next, we isolated secretory vesicles from sec1 cells ex-
pressing ROM2-HA, and examined whether Rom2-HA is
enriched in secretory vesicle fractions. Immunoblotting
analysis indicated that Rom2-HA is enriched in fractions be-
fore the peak of invertase activity (Fig. 8 B), which were
found to be those of the plasma membrane (Fig. 2 and
Fig. 4). Together with these facts, we conclude that Rom2p
is absent in secretory vesicles because the localization of
Rom2p is independent of vesicular transport.
The results raised the possibility that the scarcity of
Rom2p in secretory vesicles causes Rho1p to remain inactive
in secretory vesicles. To confirm this, we examined whether
1,3- -glucan is synthesized in secretory vesicles in sec1 cells
when ROM2 is overexpressed. Overexpressed Rom2-GFP in
sec1 cells was localized over entire cells (Fig. 7 D) and was
also ubiquitously observed in wild-type cells (unpublished
data), suggesting the cytoplasmic localization of overex-
pressed Rom2-GFP. In sec1 cells overexpressing ROM2, 1,3-
 -glucan was detected in secretory vesicles by immunoelec-
tron microscopy with the anti-1,3- -glucan antibody (Fig. 7
E and Table I). In wild-type cells overexpressing ROM2,
1,3- -glucan was not detected in intracellular organelles
(Table I). These results further support the theory that
Rho1p is held inactive in secretory vesicles due to Rom2p
deficiency in the organelles.
Synthesis of 1,3- -glucan causes toxic effects
To test the possibility that the activation of Rho1p in secre-
tory vesicles affects cell proliferation, we examined the
growth phenotypes of sec1 and sec6 cells overexpressing the
activated form of RHO1. Overexpression of the activated
form of RHO1 led to growth inhibition of sec1 and sec6 cells
at 31 C, a semipermissive temperature at which the temper-
ature-sensitive sec mutants can grow (Fig. 9 A). In wild-type
Figure 7. Rom2p is localized on the plasma membrane even 
when vesicular transport is blocked. (A–D) Localization of Rom2-
GFP fusion protein. rom2  cells transformed with YCpU-ROM2-GFP 
were incubated at 37 C for 2 h (A). sec1 rom2  cells transformed 
with YCpU-ROM2-GFP were incubated at 37 C for 2 h in the 
absence (B) or presence (C) of cycloheximide. sec1 rom2  cells 
transformed with YEpU-ROM2-GFP were incubated at 37 C for 2 h 
(D). Cultured cells were all fixed in methanol, and were subjected 
to observation. (E) Immunogold labeling with the anti-1,3- -glucan 
antibody in sec1 cells overexpressing ROM2. sec1 cells were 
transformed with YEpU-ROM2. Transformants were incubated at 
37 C for 2 h, and 1,3- -glucan was detected. Bar, 200 nm.
Figure 8. Subcellular fractionation analysis of Rom2p when vesicular 
transport is blocked. (A) Distribution of Rom2p on the plasma 
membrane in wild-type cells. Wild-type cells were incubated in 
YPD at 37 C for 2 h. Cell lysate was fractionated on a 20–60% 
sucrose density gradient. Top, distribution of plasma membrane 
ATPase (open circles) and sucrose density (closed circles). Bottom, 
immunoblotting analysis of Rom2-HA with an anti-HA antibody. 
(B) Distribution of Rom2p in Sephacryl™ S-1000 column fractions 
of sec1 cells. Top, distribution of plasma membrane ATPase (closed 
circles) and invertase (open circles). Bottom, immunoblotting analysis 
of Rom2-HA.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
94 The Journal of Cell Biology | Volume 162, Number 1, 2003
and sec12 cells, only a slight inhibitory effect of overexpress-
ing the activated form of RHO1 on growth was observed
(Fig. 9 A and unpublished data), suggesting that the effect is
specific to late-acting sec mutants.
The growth-inhibitory effect by overexpression of the ac-
tivated form of RHO1 depends on the synthesis of 1,3-
 -glucan. As GS-defective mutants, we used the temperature-
sensitive fks1–1154 fks2  mutant with reduced catalytic
activity of GS both at the permissive and restrictive tempera-
tures (Sekiya-Kawasaki et al., 2002). In contrast to sec1 cells
overexpressing activated RHO1, the growth inhibition of
sec1 cells overexpressing activated RHO1 was suppressed by
the introduction of the fks1–1154 and fks2  mutations at
31 C (Fig. 9 B). Further expression of FKS1 in this strain
complemented the fks1–1154 fks2  defect and thereby sup-
pressed growth inhibition (Fig. 9 B), leading to accumula-
tion of 1,3- -glucan in intracellular organelles (unpublished
data). Taking these results together, we conclude that
among the effectors of Rho1p, the activation of Fks1p/2p in
secretory vesicles causes toxic effects on cells.
Discussion
To examine the state of Rho1p in yeast cells, we have pro-
duced an antibody preferentially reacting with activated
Rho1p. This is the first antibody specifically reacting with
the active state of any small GTPase. Rho1p is homologous
to mammalian RhoA, which assumes distinct conformations
in the GDP- and GTP-bound states (Wei et al., 1997; Ihara
et al., 1998). Presumably, the antibody recognizes the con-
formation of GTP-bound Rho1p. Although it had been very
difficult to monitor the states of small GTPase in cells, it re-
cently became possible to observe the states of small GTPase
in mammalian cells by fluorescent resonance energy transfer
analysis (Mochizuki et al., 2001; Del Pozo et al., 2002),
which directly monitors the activation and localization of
small GTPase in living cells simultaneously. However, this
analytical technique may produce artifactual results because
cells need to be injected with photo-labeled proteins. In fact,
the GFP-Rho1 fusion protein exhibits a different localization
from authentic Rho1p (unpublished data). Other small GTP-
ases in the budding yeast are supposed to have their own ac-
tivation mechanisms at the organelles of their residence
(Hoyt, 2000; Nern and Arkowitz, 2000; Schmidt and Hall,
2002). However, one crucial problem of these models is that
the states of these small GTPases remain undetermined in
yeast cells. This kind of antibody will be useful in definitively
identifying the state of small GTPases in cells of yeast to
mammalian cells because it produces no known artifacts.
We found that overexpression of the activated form of
RHO1 in sec1 or sec6 cells inhibits cell proliferation, which is
dependent on the activity of Fks1p. This result suggested
that artificial synthesis of 1,3- -glucan in secretory vesicles is
unsuitable for cell proliferation. GS inactivation in intracel-
lular organelles can be explained in several ways. One possi-
bility is that the activation of GS on the plasma membrane is
required for morphological changes, whereas 1,3- -glucan
synthesis in intracellular organelles is undesirable for cell
morphology. Alternatively, 1,3- -glucan synthesis in intra-
cellular organelles may impair cell wall integrity or uniform
cell wall structure.
At the restrictive temperature, sec mutations affecting late
secretory steps cause accumulation of at least two types of
vesicles, whose sizes are indistinguishable by gel chromatog-
raphy (Harsay and Bretscher, 1995). Our data suggested
that Fks1p and Rho1p exist in the same vesicles; GS activity
measured in the presence of GTP- S was detected in secre-
tory vesicle fractions of sec1 mutant cells. Furthermore, by
immunoelectron microscopy and dot blot analyses, 1,3-
 -glucan was detected in vesicles that accumulated in sec1
Figure 9. Effect of activated RHO1 
overexpression on the growth of wild-
type and sec mutant cells. (A) Inhibition 
of cell proliferation in sec1 and sec6 
mutant cells. Wild-type (YPH500), sec1, 
and sec6 cells were transformed with a 
control vector, or YEpU-RHO1 (G19V), 
and incubated for 3 d at 31 C. [RHO1 
(G19V)] indicates the transformants with 
YEpU-RHO1 (G19V). (B) Suppression of 
inhibition by disturbing 1,3- -glucan 
synthesis. sec1 fks1–1154 fks2  cells 
were transformed with a control vector, 
YEpT-RHO1 (G19V), or YCpU-FKS1, 
and incubated for 3 d at 31 C. [RHO1 
(G19V)] and [FKS1] indicate the 
transformants with YEpU-RHO1 (G19V) 
and YCpU-FKS1, respectively.T
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mutant cells expressing activated Rho1p. These results suggest
that both Fks1p and Rho1p are transported from the Golgi to
the plasma membrane in particular secretory vesicles.
The membrane fraction of sec12 and sec16 mutant cells
transferred to the restrictive temperature exhibited reduced
GS activity even in the presence of GTP- S. The reduced ac-
tivity was not recovered by addition of the activated form of
Rho1p (unpublished data). Only a minor effect of overex-
pressing activated RHO1 on growth of sec12 mutant cells was
observed. These results suggested that GS is also kept inactive
in the ER by mechanism(s) other than Rho1p inactivation.
One conceivable mechanism for the inactivation of GS in this
organelle is through its inhibition by phytosphingosine, an in-
termediate of sphingolipid, as phytosphingosine is a potent
inhibitor of GS and is localized to the ER (Abe et al., 2001).
Thus, there may be two mechanisms, inhibition by phyto-
sphingosine and inactivation of Rho1p, to prevent GS from be-
ing activated in the ER. These mechanisms may doubly repress
the activity of the cell wall–synthetic enzyme within the ER.
After synthesis in the ER, Rho1p is geranylgeranylated by
geranylgeranyl transferase, a modification required for trans-
port and attachment of Rho1p to the membrane (Ohya et
al., 1996; Inoue et al., 1999). That Rho1p is transported to
the plasma membrane through vesicular transport after
geranylgeranylation is indicated by the following lines of
evidence. First, like many membrane-bound proteins trans-
ported through the secretory pathway, Rho1p is not
localized on the plasma membrane in sec mutants. Second,
Rho1p accumulates in secretory vesicles in sec1 cells at the
restrictive temperature. Third, Rho1p is largely found in the
membrane fraction in sec12 cells at the restrictive tempera-
ture (unpublished data), whereas it is located in the soluble
fraction in a mutant with a defect in geranylgeranyl trans-
ferase (Ohya et al., 1996). Together, Rho1p is probably
modified with the geranylgeranyl group in the ER and trans-
ported to the plasma membrane through the secretory path-
way. However, this mechanism may not apply to all pren-
ylated proteins because transport of another prenylated
protein, a-factor, was unaffected by blocks on the secretory
pathway (Kuchler and Thorner, 1992).
In this investigation we showed the independence of
Rom2p localization on normal vesicular transport. Like
other GEFs, Rom2p contains a Dbl homologous domain
and a pleckstrin homology domain (Ozaki et al., 1996;
Lorberg et al., 2001). As it was shown that the pleckstrin ho-
mology domain of Rom2p interacts with PI4,5P2 and a de-
fect in PI4,5P2 synthesis leads to delocalization of Rom2p
(Audhya and Emr, 2002), the localization of Rom2p de-
pends on that of PI4,5P2. One possible mechanism for the
transport of Rom2p to the plasma membrane is Rom2p re-
cruitment to the plasma membrane by PI4,5P2, which is
transported to the plasma membrane through a pathway dis-
tinct from normal vesicular transport. Further study is
needed to resolve this question.
Materials and methods
Strains and growth conditions
YPH499 and YPH500 were used as the wild-type strains. SEY5016 (sec1–1),
ANS6–2D (sec6–4), ANY8–5A (sec12–1), and ANS16–1B (sec16–2)
strains were provided by A. Nakano (RIKEN, Japan) and R. Schekman
(University of California, Berkeley, Berkeley, CA). YOC2573 (sec1–1
wsc1 ), YOC2576 (sec1–1 rom2 ), and YOC3123 (sec1–1 end4 ) were
constructed by PCR-mediated gene disruptions described previously
(Sekiya-Kawasaki et al., 2002). Strain YOC3018 (sec1 fks1–1154 fks2 )
was produced by a successive cross between SEY5016 and YOC1087
(fks1–1154 fks2 ). Yeast cells were grown in rich medium (YPD; 1% bacto
yeast extract [Difco], 2% bacto peptone [Difco], and 2% glucose [Wako
Chemicals]), or in appropriately supplemented synthetic growth medium
(SD; 0.67% yeast nitrogen base [Difco] and 2% glucose). For -Ura and -
Trp selections, 0.5% casamino acid (Difco) was added to SD.
Plasmids
Plasmids pYO821 (YEpU-RHO1 (G19V)), pYO964 (YCpU-RHO1 (G19V)),
pYO965 (YCpU-RHO1 (Q68L)), pYO2326 (YCpL-FKS1), pYO2366
(YEpU-ROM2), and pYO821 (YEpU-RHO1 (G19V)) are as described pre-
viously (Sekiya-Kawasaki et al., 2002). pYO2515 (YCpU-WSC1-HA) and
pYO2516 (YCpU-ROM2-HA) were produced by introducing a PCR-ampli-
fied fragment containing the corresponding ORF and the 0.5-kb upstream
region into pTS903CU, a gift from Y. Kikuchi (University of Tokyo, Tokyo,
Japan). Introduction of a PCR-amplified fragment containing the ORF of
WSC1 and ROM2 and the 0.5-kb upstream region into pRS316-GFP,
which was constructed for the expression of fusion genes with EGFP
(CLONTECH Laboratories, Inc.), resulted in pYO2517 (YCpU-WSC1-GFP)
and pYO2518 (YCpU-ROM2-GFP), respectively. pYO2519 (YEpU-ROM2-
GFP) was constructed by introducing a fragment containing both the 0.5-
kb upstream region and ROM2-GFP from pYO2518 into a 2- m origin
vector, pYO326 (Sekiya-Kawasaki et al., 2002).
Morphological observations
Procedures for immunofluorescence microscopy were as described previ-
ously (Pringle et al., 1989). Anti-Fks1p/2p (2D8, a gift from S.B. Inoue and
T. Watanabe; Nippon Roche, Kamakura, Japan), and anti-Rho1p antibod-
ies were used as primary antibodies, whereas Alexa Fluor
® 488 goat anti–
mouse and Alexa Fluor
® 546 goat anti–rabbit antibodies (Molecular
Probes, Inc.) were used as secondary antibodies. Cells were viewed under
an imaging microscope (Axioplan 2; Carl Zeiss MicroImaging, Inc.). De-
convolution was performed using AutoDeblur software (AutoQuant Imag-
ing, Inc). GFP fusion proteins were observed as formerly described (Guo et
al., 2001). In brief, cells were collected, fixed in methanol at  20 C for 10
min, washed with acetone at  20 C, washed with PBS three times, resus-
pended in PBS, and subjected to observation. Cells were viewed under a
microscope (Leitz DMR; Leica). Images were captured using a CCD cam-
era (CoolSNAP HQ; Nippon Roper) and MetaMorph
® imaging software
(Universal Imaging Corp.). All the images presented were processed using
Adobe Photoshop
® software.
Incorporation of [
14C]glucose into 1,3- -glucan
Cells were grown to early log phase at 25 C and were then cultured at ei-
ther the permissive or the restrictive temperature for 2 h. The cultured cells
were diluted to OD600 of 0.5 with 1 ml 0.5% glucose medium containing
10  Ci [
14C]glucose, and were labeled for 2 h. The labeled cells were har-
vested and extracted with 1 N NaOH. The insoluble pellets were resus-
pended in 10 mM Tris/HCl, pH 7.5, containing 5 mg/ml zymolyase 100T
(Seikagaku) and incubated for 20 h at 37 C. After digestion, the zymolyase-
resistant material was removed by centrifugation (15,000 g for 20 min) and
the supernatant was filtered through a microcon-10 membrane (Amicon Bio-
separations). The flow-through fraction was dried by a vacuum evaporator
and applied to Unifilter-GF/C (Packard Instrument Co.). The differences in
the incorporation rates in strains were normalized by  OD600, measured
before and after the labeling period. Because a significant value of  OD600
was required for the normalization, we preferred mild condition (34 C) as
the restrictive temperature. The small incorporation observed in sec mutant
cells at the restrictive temperature may be due to this mild condition.
Preparation of the membrane fraction and measurement 
of in vitro GS activity
Cells were grown at 25 C in 1 l medium in a 2-l flask until the OD600 of the
culture reached one. All the following procedures were performed at 4 C.
The cells were harvested, washed with 1 mM EDTA, and disrupted by
Multi-beads shocker (Yasui Kikai) with 10-ml glass beads in 20 ml of the
breaking solution consisting of 0.5 M NaCl and 1 mM EDTA with 1 mM
phenylmethylsulfonyl fluoride. The crude lysate was centrifuged at 1,500 g
for 5 min so that cell debris and unbroken cells are sedimented. The super-
natant was centrifuged at 100,000 g for 30 min in a rotor (model RP70T;T
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Hitachi) with Himac CP 65 (Hitachi). The resultant pellet was suspended
(the membrane fraction) with the membrane buffer (50 mM Tris-HCl, pH
7.5, 10 mM EDTA, 1 mM  -mercaptoethanol, and 33% glycerol) and ho-
mogenized with a Dounce homogenizer. GS activity of the membrane
fraction was measured after an excess amount of GTP- S was added and
incubated for at least 30 min on ice.
Purification of secretory vesicles
Secretory vesicles were purified as specified before (Walworth and No-
vick, 1987) with some modifications. Cells were grown at 25 C, harvested,
resuspended in low glucose medium, and after incubation for 2 h at 37 C,
were harvested and washed with ice-cold 10 mM NaN3. The washed cells
were resuspended in spheroplasting buffer (1.4 M sorbitol, 50 mM KPi, pH
7.5, 10 mM, 40 mM  -mercaptoethanol, and zymolyase-100T), and incu-
bated at 37 C for 45 min. The spheroplasts were resuspended in lysis
buffer (0.8 M sorbitol, 10 mM triethanolamine, and 1 mM EDTA, adjusted
to pH 7.2 with acetic acid and protease inhibitors), and lysed by a Dounce
homogenizer. After cell debris was removed, the supernatant was centri-
fuged at 13,000 g for 20 min in a rotor (model RP70T; Hitachi). The super-
natant was centrifuged at 100,000 g for 1 h in the same rotor. The resultant
pellet was resuspended in the lysis buffer, and loaded on a 100   1.6 cm
Sephacryl™ S-1000 column (Amersham Biosciences). The column was
eluted, and 4-ml (Fig. 2 and Fig. 8 B) or 3-ml (Fig. 4 C) fractions were col-
lected. For GS activity measurements (Fig. 2), 3 ml of each fraction was
centrifuged at 100,000 g for 1 h at 4 C in a rotor (S100AT5; Hitachi), and
the pellet was resuspended with 200  l of the aforementioned membrane
buffer. The plasma membrane ATPase activity (Serrano, 1988) and inver-
tase activity (Harsay and Bretscher, 1995) in the fractions were assayed as
described previously.
Fractionation on sucrose density gradients
Cell organelles were fractionated on equilibrium density gradients accord-
ing to previously published procedures (Roberg et al., 1999) with several
modifications. Cultures were grown in 1 l medium until the OD600 of the
cultures reached one. Cells were resuspended in 5 ml STE 10 (10% su-
crose in the breaking solution with protease inhibitors), and lysed with
glass beads by Multi-beads shocker. The lysate was cleared of debris by
centrifugation at 300 g for 3 min, and the supernatant was layered on top
of 20-ml 20–60% linear sucrose gradient in the breaking solution. Samples
were centrifuged at 100,000 g for 36 h at 4 C in a rotor (P28S; Hitachi),
and fractions of 1 ml were collected from the top of the gradient.
Antibody production and affinity purification
Anti-Rho1p and anti-actRho1p antibodies were raised against recombi-
nant Rho1 and Rho1 (G19V) proteins, respectively. Approximately 0.1 mg
of either protein (a gift from S.B. Inoue and T. Watanabe) was injected into
rabbits, and antiserum was obtained after the ninth injection of the anti-
gen. The anti-Rho1p antibody raised was affinity-purified by a HiTrap
NHS-activated column (Amersham Biosciences) with 1 mg of recombinant
GST-Rho1 protein bound. The column was eluted with 3 ml of 100 mM
glycine at pH 2.5, and the eluted fraction was concentrated with Cen-
triprep (Amicon Bioseparations) after addition of 0.3 ml 1 M Tris/HCl, pH
8.0. On the other hand, the anti-actRho1p antibody collected was affinity
purified by a HiTrap NHS-activated column with 1 mg recombinant Rho1
(G19V) protein bound. The column was eluted with 10 ml of 100 mM gly-
cine, pH 2.5. The eluted fraction was mixed with 1 ml of 1 M Tris/HCl, pH
8.0, and was loaded on an NHS-activated column with 1 mg recombinant
GST-Rho1 protein bound. The flow-through fraction was concentrated
with Centriprep.
Immunoprecipitation of Rho1p
Recombinant wild-type Rho1 protein was suspended in IP buffer (20 mM
Tris/HCl, pH 8.0, 5 mM MgCl2, 1 mM EDTA, 0.6% CHAPS, and 2 mM
phenylmethylsulfonyl fluoride), and was incubated for 1 h at 4 C without
nucleotides or with either 10  M GTP- S or GDP. Either the anti-Rho1p or
the anti-actRho1p antibody was used at 1:500 dilution. After a 2-h incuba-
tion at 4 C, protein A Sepharose beads (Amersham Biosciences) were
added and the samples were further incubated for 2 h at 4 C. The beads
were then washed with IP buffer, from which proteins were eluted by boil-
ing in SDS sample buffer for 10 min. Protein samples were loaded on SDS-
polyacrylamide gels, transferred to PVDF membranes (Amersham Bio-
sciences), and blotted with a guinea pig antiserum against Rho1p (Ohya et
al., 1996). After reaction with ECL-Plus (Amersham Biosciences), Rho1p
was detected and quantified with a cooled CCD camera (LAS-1000plus;
Fuji Photo Film).
For immunoprecipitation of activated Rho1p from fractions from gel
chromatography, 0.1 M NaCl and 0.6% CHAPS were added to 1 ml of the
collected fractions. Subsequently, the suspension was left at 4 C for 2 h
and the activated Rho1p was immunoprecipitated from the fractions and
detected as described above.
Immunoelectron microscopic analysis
Thin sections of yeast cells were prepared by the freeze-substituted fixation
method as described previously (Sun et al., 1992), except that HPM010
(BAL-TEC AG) or EMCPS (Leica) for cell freezing and EMAFS (Leica) for
warming were used. For 1,3- -glucan immunolabeling, a mouse mAb
against 1,3- -glucan (Biosupplies) and a secondary antibody conjugated
with 10-nm gold particles were used. The labeled thin sections were
viewed under an electron microscope (model H7600; Hitachi) at 100 kV.
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